Non-erythropoiesis-stimulating agent, non-iron therapies for the management of anaemia: protocol for a scoping review

Abstract

IntroductionPreoperative anaemia is associated with poor postoperative outcomes and is the strongest predictor of allogenic blood transfusion, which contributes further to patient morbidity. Emphasis has been placed on correcting anaemia prior to surgery to mitigate these outcomes. Conflicting evidence exists regarding the benefit of currently recommended interventions. With greater understanding of iron haemostasis and erythropoiesis, novel therapies have been identified. These are at varying stages of development with some demonstrating promising results in patients with chronic kidney disease. It is not known how these agents have been studied outside this population, particularly in the perioperative context. To address this, we will conduct a scoping review of the published literature to chart the evidence.Methods and analysisThe scoping review will be reported according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses Extension for Scoping Reviews framework. The electronic database search will include Scopus, MEDLINE (Ovid) and Excerpta Medica database (Ovid), with no language restrictions, and will include all publications since 1 January 2010. This review will have three objectives: (1) to describe the mechanisms of action for novel agents, (2) to describe the level of evidence and stage of development of novel agents in a perioperative setting, and (3) to determine the potential agents suitable for prospective controlled trials in a preoperative or postoperative patient cohort and aiming to improve patient-centred outcomes. The review process will involve two reviewers with a third reviewer resolving disagreements. Data will be extracted and organised with subsequent analysis.Ethics and disseminationThis scoping review does not require research ethics approval. The results will be published in a peer-reviewed journal and inform the development of future prospective trials based on established evidence from potential therapeutic agents.Trial registration numberThis protocol has been registered prospectively on the Open Science Framework registry (DOI:10.17605/OSF.IO/SM3UH, https://osf.io/sm3uh/?view_only=39876ccf7a4348dfbd566535b957a7db).Cite Now

Non‐erythropoiesis stimulating agent, non‐iron therapies for the management of anemia: A scoping review

“…This scoping review was conducted in accordance with the methodological principles described by Arksey and O'Malley, 35 and reported in keeping with the Preferred Reporting Items for Systematic Reviews and Meta‐analyses Protocols Extension for Scoping Review guideline (PRISMA‐ScR) (Appendix S1). 36 A protocol was registered with Open Science Framework was published previously 37 . A search strategy was developed following a preliminary literature search with input from information specialists at the University of Western Australia (Appendix S2).…”

“…36 A protocol was registered with Open Science Framework was published previously. 37 A search strategy was developed following a preliminary literature search with input from information specialists at the University of Western Australia (Appendix S2).…”